DS

Dr. Saar Gill

Founder

Interius BioTherapeutics

Interius BioTherapeutics Pipeline

DrugIndicationPhase
In vivo CAR-T programsOncology (unspecified cancers)Pre-clinical
Platform-derived therapeuticsAutoimmune conditionsPre-clinical/Research